able to understand what the intrusion ofdisease means to a patient's personal and professional life, and will then be able to use their particular professional skills to offer advice and support.
There is abundant evidence to show that the majority of patients with cancer prefer to talk about their disease, and the burden of proof has now moved to those who say 'None of my patients want to know', to demonstrate how lack of communication benefits anyone.
Problems still arise when the consultant, as a matter of principle or routine, does not wish to involve patients in decisions, or wishes them to remain in ignorance, or has deliberately misinformed them. Whether or not to be party to this conspiracy of silence or deceit raises many difficult professional and ethical issues.
On the other hand, where doctors, nurses and other health professionals are working together as a team with patients and their families, communication at all levels becomes accepted as part of patient care. Although it is up to the patient to decide with whom he wishes to discuss his problems, nurses, knowing the information being imparted to the patient from a variety of sources, can help him to assimilate this knowledge and correct any misinterpretation. A multidisciplinary approach in which the informed patient works with the health team to combat his disease is a most effective form of clinical management for patients with cancer. Patients with cancer, particularly those treated by major surgery, have to adjust t9 the obvious physical effects of the treatment as well as to the disease itself. The problems they may encounter are particularly well illustrated by women with breast cancer treated by mastectomy, and there is an extensive literature on their psychological adjustment and rehabilitation. Studies fall broadly into three groups: (1) those concerned with the extent of psychological and social morbidity in newly diagnosed cancer patients and in patients following mastectomy; (2) those searching for indices of vulnerability which might serve to distinguish the cancer patient who fails to adjust from the one who resumes her former activities with vigour and determination; (3) those suggesting ways in which patients might be helped to adjust, either by the creation of additional services, or within the framework of the present services.
Extent 0/psychological and social morbidity
Studies of both newly diagnosed cancer patients and patients who have had mastectomy are relevant since the breast cancer patient must adjust to the idea that she has a potentially fatal disease, and to a disfiguring change in her body. Most research on this topic has unfortunately not compared the incidence of symptoms in mastectomy patients with that in control subjects of the same age, although there are some recent exceptions (Morris et 01. 1977; Maguire et al. 1978) . The areas of morbidity examined include psychiatric symptoms, especially depression, sexual, and work difficulties. From a variety of studies, using various methods, and of variable merit, it seems that 1-2 years after diagnosis and primary treatment for breast cancer, between 11% and 25% of patients will be moderately/severely depressed (compared with 8-10% of controls); between 8% and 35% of patients will have an impaired sex life; and 27-29% of patients will not have resumed their working role.
